Advertisement
Canada markets closed
  • S&P/TSX

    23,003.09
    -24.06 (-0.10%)
     
  • S&P 500

    5,495.52
    +24.47 (+0.45%)
     
  • DOW

    40,736.96
    -92.63 (-0.23%)
     
  • CAD/USD

    0.7345
    -0.0003 (-0.05%)
     
  • CRUDE OIL

    65.97
    +0.22 (+0.33%)
     
  • Bitcoin CAD

    78,569.09
    +946.47 (+1.22%)
     
  • XRP CAD

    0.74
    +0.01 (+0.80%)
     
  • GOLD FUTURES

    2,544.30
    +1.20 (+0.05%)
     
  • RUSSELL 2000

    2,097.44
    -0.34 (-0.02%)
     
  • 10-Yr Bond

    3.6460
    -0.0510 (-1.38%)
     
  • NASDAQ futures

    18,806.50
    -57.50 (-0.30%)
     
  • VOLATILITY

    19.08
    -0.37 (-1.90%)
     
  • FTSE

    8,205.98
    -64.86 (-0.78%)
     
  • NIKKEI 225

    35,898.51
    -260.65 (-0.72%)
     
  • CAD/EUR

    0.6662
    -0.0003 (-0.05%)
     

Abbott (ABT) Just Overtook the 200-Day Moving Average

Abbott (ABT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ABT broke through the 200-day moving average, which suggests a long-term bullish trend.

The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level.

ABT has rallied 7.6% over the past four weeks, and the company is a Zacks Rank #2 (Buy) at the moment. This combination suggests ABT could be on the verge of another move higher.

Looking at ABT's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 9 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well.

Investors may want to watch ABT for more gains in the near future given the company's key technical level and positive earnings estimate revisions.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Abbott Laboratories (ABT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research